Concepedia

Publication | Closed Access

Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study

DOI

151

Citations

13

References

2014

Year

Silvio Danese, J Rudziński, Wolfgang Brandt, Jean-Louis Dupas, Laurent Peyrin‐Biroulet, Yoram Bouhnik, D Kleczkowski, Peter Uebel, Milan Lukáš, Mikael Knutsson,
Gut

Abstract

ClinicalTrials.gov number: NCT01482884.

References

YearCitations

Page 1